- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04719390
BabySTEPs: Supportive Texts to Empower Parents
Study Overview
Detailed Description
The pilot MRT is designed preliminary to assess feasibility and acceptability of the MRT design, as well as to compare acceptability and preliminary impact of two types of intervention messages in a sample of 65 postpartum mothers with histories of heavy episodic drinking.
The MRT was conducted using the Catalyst app, which was available for download on participants' personal smartphones. Participants completed ecological momentary assessment (EMA) surveys twice per day for 28 days. Following EMA completion, participants were randomized to receive a maternal-focused message (.40 probability), a drinking-focused message (.40 probability), or no message (.20 probability). If randomized to receive a message, participants would receive an intervention message that was selected at random from one of the 60 available messages in that condition, with each message having an equal probability of being selected. Following message receipt, participants were sent two questions asking whether the message was helpful (yes, no, not sure) and how the message made them feel (empowered, judged, understood, seen, confident, misunderstood, bad about myself, good, bad). Outcomes were assessed via EMA 15 minutes after delivery of the intervention message.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10017
- Partnership to End Addiction
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adult women ages 18-45 years who gave birth to an infant that will remain in their care
- English-speaking
- own a text-enabled cell phone
- report a score of 2 or higher on the T-ACE alcohol risk screener AND (a) drinking weekly or more often in the past month OR (b) having 4 or more standard drinks at least monthly in the 12 months prior to becoming pregnant.
Exclusion Criteria:
- women age 46 years or older
- women who did not recently give birth to an infant
- women who gave birth to an infant but that infant is not in their care
- individuals who do not speak English
- women who report a score of less than 2 on the T-ACE alcohol risk screener
- women who do not report either weekly or more drinking in the past month OR having 4 or more standard drinks at least monthly in the 12 months prior to becoming pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Text Messaging Intervention
After each daily EMA survey, participants were micro-randomized to (1) receive a maternal-focused message (.40 probability); (2) receive a drinking-focused message (.40 probability) or (3) receive no message (.20 probability).
|
Maternal-Focused Message: When randomized to receive a maternal-focused message, participants will receive a message that is focused on the transition to motherhood and the joys and challenges of caring for a newborn. Drinking-Focused Message: When randomized to receive a drinking-focused message, participants will receive a message that is focused on reducing alcohol use. All messages of both types are designed to map onto behavior change techniques that are empirically supported for alcohol use. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MRT Feasibility
Time Frame: Surveys were delivered 4 times per day (2 EMA, 2 proximal outcome surveys) on each of the 28 days of the intervention period.
|
Proportion of EMA surveys completed out of total delivered.
|
Surveys were delivered 4 times per day (2 EMA, 2 proximal outcome surveys) on each of the 28 days of the intervention period.
|
|
MRT Acceptability
Time Frame: Assessed on the final day of the 28-day MRT.
|
MRT acceptability was assessed via a 9-item scale assessing burden associated with the study.
Cronbach's alpha in the sample was 0.88.
Items were rated on a 1 to 7 scale, with higher scores reflecting higher burden.
Scores on each item were averaged to create a total score ranging from 1 to 7. The average total score is reported.
|
Assessed on the final day of the 28-day MRT.
|
|
Alcohol Use
Time Frame: Assessed at each proximal outcome survey, twice per day for 28 days.
|
At each EMA survey/randomization decision point, participants were asked if they drank any alcohol in the prior hour (yes or no).
At each proximal outcome survey (15 minutes after randomization), participants were asked if they drank any alcohol since their last survey (yes or no).
The outcome is reported as the percent of participants who endorsed alcohol use on the proximal outcome survey, after randomization.
|
Assessed at each proximal outcome survey, twice per day for 28 days.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal Self Efficacy
Time Frame: Assessed at each proximal outcome survey, twice per day for 28 days, regarding the next hour.
|
At each proximal outcome survey, participants rated their confidence in their ability to meet their baby's needs over the next hour on a scale of 1 (not at all confident) to 7 (extremely confident).
Higher numbers indicated greater maternal self-efficacy.
|
Assessed at each proximal outcome survey, twice per day for 28 days, regarding the next hour.
|
|
Drinking Self-Efficacy
Time Frame: Assessed at each proximal outcome survey, twice per day for 28 days, regarding the next hour.
|
At each proximal outcome survey, participants rated their confidence in their ability to avoid drinking alcohol in the next hour on a scale of 1 (not at all confident) to 7 (extremely confident).
Higher scores indicated higher drinking self-efficacy.
|
Assessed at each proximal outcome survey, twice per day for 28 days, regarding the next hour.
|
|
Motivation
Time Frame: Assessed at each proximal outcome survey, twice a day for 28 days, regarding the next hour.
|
At each proximal outcome survey, participants were asked to rate how committed they are to not drink alcohol in the next hour on a scale of 1 (not at all committed) to 7 (extremely committed).
Higher scores indicate higher motivation to avoid alcohol.
|
Assessed at each proximal outcome survey, twice a day for 28 days, regarding the next hour.
|
|
Urge to Drink
Time Frame: Assessed at each proximal outcome survey, twice a day for 28 days.
|
At each proximal outcome survey, participants rated the extent of their urge to drink "right now" on a scale from 1 (very low) to 7 (very high).
Higher scores indicate higher urge to drink alcohol.
|
Assessed at each proximal outcome survey, twice a day for 28 days.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sarah Dauber, PhD, Partnership to End Addiction (formerly CASAColumbia)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BabySTEPs
- R34AA028407 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
Penn State UniversityNot yet recruiting
-
Boston University Charles River CampusActive, not recruiting
-
The Hong Kong Polytechnic UniversityNot yet recruitingHazardous Drinking | Harmful Alcohol Use
-
University of WyomingRecruiting
-
Binghamton UniversityNot yet recruitingUnderage Drinking | Drinking, Teen | Adolescent Alcohol UseUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
The University of Hong KongRecruitingmHealth Intervention | AlcoholHong Kong
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
Clinical Trials on Text Message
-
University of California, San FranciscoUniversity of WashingtonCompleted
-
University of WashingtonUniversity of Illinois at Chicago; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency Syndrome | Circumcision, Male | Patient Compliance | Cellular PhoneKenya
-
Texas Tech University Health Sciences CenterTexas Tech UniversityCompletedBreast Cancer FemaleUnited States
-
University of WashingtonUniversity of California, San Francisco; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency SyndromeKenya
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Columbia UniversityPfizerCompletedVaccinationUnited States
-
Washington University School of MedicineThe Craig H. Neilsen FoundationRecruiting
-
Wake Forest University Health SciencesCompleted
-
New York City Health and Hospitals CorporationWithdrawn